Citi Maintains 'Buy' on Pediatrix Medical Group (PDX), Drops Price Target
PDX Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
Citi maintains a 'Buy' on Pediatrix Medical Group Inc (NYSE: PDX), lowers price target from $66 to $55.
Citi analyst says, "PDX lowered 3Q08 EPS guidance by 3-4c (3.5-4.5%) due to adverse payor mix shift that began in August (implies a 100-200bp shift). We believe this mix shift will continue as long as unemployment is rising (particularly CA, FL & TX) and have revised our forward estimates lower to reflect such a trend...We are lowering 2009 from $3.65 to $3.40 to reflect the recent payor mix shift + an additional 100bp deterioration in 2009 and a 2% decline in SS NICU volumes. We believe this constitutes a reasonable worst-case scenario."
Pediatrix Medical Group, Inc. (Pediatrix) is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care.
Citi analyst says, "PDX lowered 3Q08 EPS guidance by 3-4c (3.5-4.5%) due to adverse payor mix shift that began in August (implies a 100-200bp shift). We believe this mix shift will continue as long as unemployment is rising (particularly CA, FL & TX) and have revised our forward estimates lower to reflect such a trend...We are lowering 2009 from $3.65 to $3.40 to reflect the recent payor mix shift + an additional 100bp deterioration in 2009 and a 2% decline in SS NICU volumes. We believe this constitutes a reasonable worst-case scenario."
Pediatrix Medical Group, Inc. (Pediatrix) is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care.
You May Also Be Interested In
- Barclays Maintains an 'Equalweight' on Trina Solar (TSL); Waiting on Growth in Gross Margins and Stabilized Opex
- Barclays Maintains an 'Overweight' on Big Lots (BIG); Tweaking Estimates After Q1 Miss
- Auriga Cuts PT and Estimates on HEICO (HEI); Cautious on Decelerating FSG Growth
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
